Autoimmune Disease Featured Articles
-
A New Model For Life Sciences Collaboration
11/1/2011
Getting things done. How does a business get things done with invasive regulations, bureaucracy, and uncertain taxes and personnel costs? These are significant barriers. By Fred Olds
-
Integrative Biology: At The Tipping Point
10/7/2011
I recently met Gustavo Salem, VP and general manager of the Biological Systems Division at Agilent Technologies. Salem believes integrative biology is at a tipping point for producing major breakthroughs in the drug development. By Rob Wright, Chief Editor, Life Science Leader magazine
-
Technology Speeds Scientific Research, Generates New Knowledge
8/18/2011
The mid-1970s was an interesting time, as Seattle – and the world – sat poised on the brink of a new era of technology. Microsoft was in its infant stages, practical use of the Internet was still in the distant future, and research into infectious diseases, quaintly called “tropical diseases” at the time, was practically nonexistent in America.
-
Article: Trial Recruitment Without 'Trial And Error:' Validating Protocols And Identifying Investigators With Secondary Data Sources
7/25/2011
For the past 10 years, pharmaceutical marketers have been using comprehensive, secondary databases and sophisticated analytics to reach the right physicians with the right educational messages. That same information and analytical approach can be used just as effectively to help clinical research organizations (CROs) select investigators and reach the right potential subjects for clinical studies. By Michel Denarie, IMS Health
This website uses cookies to ensure you get the best experience on our website. Learn more